ArticleIndian heart journal

ADDition of DAPAgliflozin, Sodium-Glucose Cotransporter-2 Inhibitor to Angiotensin Receptor Blocker-Neprilysin Inhibitors Non-Responders in Patient with Refractory Heart Failure with Reduced Ejection Fraction (ADD DAPA trial).

Pankaj Jariwala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.